MedTech Acquisition Corporation
MTACW
NASDAQ Capital Market0.22
USD
+0.02
- -
CIK
0001826667
Return %
Stock
S&P500
1Y
162.65
18.21
3Y
-87.54
63.29
5Y
-87.54
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- IPO Date
- Feb 9, 2021
- CIK
- 0001826667
- Similar Companies
- Business
- MedTech Acquisition Corporation (MTACW) operates as a special purpose acquisition company focused on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with businesses primarily in the healthcare and medical technology sectors in the United States and other developed markets; it offers no independent products or services beyond its blank check structure. Founded in 2020 and headquartered in Greenwich, Connecticut, the company targets medtech entities including medical devices, diagnostics, and digital health innovators. In August 2023, MedTech completed a reverse merger with TriSalus Life Sciences, Inc., pursuant to which MedTech was acquired, its common stock and warrants transitioned to TriSalus symbols TLSI and TLSIW, and MTACW warrants continued trading separately post-transaction amid the SPAC's completion of its initial business combination objective. Previously, MedTech announced but mutually terminated a business combination agreement with Memic Innovative Surgery Ltd. in March 2022 due to market volatility. The entity maintains no ongoing operations independent of its merger activities and warrant structure.